Kyowa Hakko Kogyo Introduces SoyScienceTM and the New Technology of Soy at VendorWorks Seminar at SupplySide East

Studies show SoyScienceTM helps maintain healthy cholesterol levels.

 Kyowa Hakko U.S.A., a subsidiary of Kyowa Hakko Kogyo, presented a clinical trial at a SupplySide East VendorWorks seminar in Baltimore, MD, Friday, May 7, that used SoyScience, a soy protein/phospholipid complex system, showing patients with high cholesterol taking 3g of SoyScience daily (Biosci.Biotechnol.Biochem., 65(1), 72-78, 2001), had their blood cholesterol (total and LDL) return to normal levels. The study information was presented by Yoichiro Sugimura, Japanfs leading expert on soy peptides.

 Sugimura noted that a study at Gifu University and Tokushima University in Japan, also suggested that SoyScience helps promote healthy cholesterol levels within normal range.

 Sugimura reviewed the molecular structure of soy protein, function of soy protein hydrolysate/enzymatic-modified lecithin complex, protein and lipid binding mechanisms of soy protein and soy phospholipids, and SoyScience clinical, safety and stability studies. The Food and Drug Administration (FDA), considers SoyScience as Generally Recognized as Safe (GRAS).

 To learn more about SoyScience and the complete line of ingredients from Kyowa Hakko, as well as a copy of the presentation by Yoichiro Sugimura at SupplySide East 2004, contact Kohei Yamamoto at Kyowa Hakko U.S.A., (212) 319-5353, ext. 210.